Atrial Fibrillation, Cryoablation
Conditions
Brief summary
This is a prospective trial investigating the effectiveness of a modified MRI preparatory pulse sequence to improve pulmonary vein isolation visualization.
Interventions
Cylindrical Navigator Preparatory Pulse Sequence
Cardiac Magnetic Resonance Imaging
Sponsors
Study design
Eligibility
Inclusion criteria
* Men or non-pregnant women * A diagnosis of symptomatic paroxysmal or recently persistent atrial fibrillation with a documented successful cardioversion within 4 months of the procedure * Documented treatment failure or intolerance of at least 1 anti-arrhythmic medication used to control atrial fibrillation.
Exclusion criteria
* Contraindication to MRI, such as implanted incompatible metal prosthesis, or subject size exceeds bore or table limits * Allergy to gadolinium-based contrast agent * Previous atrial fibrillation ablation * Renal dysfunction (estimated GFR \<60 mL/min/1.73m2) within 6 months * Unwilling to provide informed consent for this protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood Pool Corrected Signal Intensity | Through study completion, an average of 1 year |
| Imaging Failure Rate | Through study completion, an average of 1 year |
| Extent of Detected LGE Signal Correlate to the Respiratory Navigator Scheme | Through study completion, an average of 1 year |
Countries
United States